Independent provider comparison

Updated September 27, 2026

Embody vs Hers: Which GLP-1 provider is better?

A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.

Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.

By Iacob Pastina, Independent Researcher & Publisher
Updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
37 providers verified independently·Independent researchHow we rank →

The short decision

Which should you choose?

We would start with Embody for a low-entry-cost compounded injection, if your clinician considers it appropriate. Its public one-month semaglutide plan is $79 with medication included. Choose Hers if you want a women-focused platform with FDA-approved pill and injection options, care-team support and app tracking. Hers charges membership separately from medication. Both can be useful services; our recommendation turns on whether you want a simple injection bundle or the broader treatment choices at Hers.

Both providers pay us a commission through our links. Commissions do not set scores or the facts compared here. How we make money.

Sources: Embody catalogue and payment terms · Hers program and care details

Embody logo

Embody

#17 of 37
7.3/10

Our pick for a simple cash-pay injection plan

Visit Embody
Hers logo

Hers

#26 of 37
5.3/10

Choose Hers for a women-focused care platform

Visit Hers

Side by side

Embody vs Hers at a glance

Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.

FeatureEmbodyHers

Why each one

Embody

Publishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied.

Hers

A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options.
Our Score7.3/105.3/10
Headline Pricefrom $69/mo$188 first month, then $298/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoNo

Best For

Embody

People who want to compare Embody's published plan menu with its separate monthly promotion and will confirm the exact charge, term and refund rules before paying

Hers

Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path

Watch out for

Embody

Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date.

Hers

Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
Ranking#17#26
Get startedVisit EmbodyVisit Hers

For Embody's one-month prices, prepaid totals and conflicting billing terms, read the Embody price and payment breakdown.

Trade-offs

Strengths and cautions compared

Embody

Pros

  • +Publishes a complete price ladder for both molecules, so what each advertised rate costs up front is checkable: semaglutide $79/$76/$73/$69 and tirzepatide $129/$126/$123/$119 across one, three, six and twelve months.
  • +One-month injection prices of $79 for semaglutide and $129 for GLP-1 + GIP were visible in Embody's catalogue on September 20, 2026. The FAQ says the selected rate holds within the chosen plan.
  • +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.

2 more documented strengths

  • +Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and limited medical-disqualification refund exception are readable before you pay.
  • +Replies to every negative Trustpilot review, usually within 24 hours.

Cons

  • −Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date.
  • −The public catalogue shows $69/$119 as twelve-month equivalents paid up front at $828/$1,428, while a separate promotion advertises those amounts monthly. Embody's April-dated terms still list different introductory and fixed-price programs. We have not verified which terms govern the final offer. Confirm the first charge, recurring charge and commitment before paying.
  • −Trustpilot showed 3.8 / 5 across 8,121 reviews on 2026-09-20, while the landing page advertised 4.8 on our prior check. The Trustpilot profile includes merged reviews from another profile, and individual reports cover different pricing periods. It is not a measure of clinical quality.

3 more documented cautions

  • −Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
  • −Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
  • −Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others. Embody and SnagRx both advertise $69 semaglutide and $119 tirzepatide, but their verified payment commitments differ. Read our SnagRx review, then compare Embody and SnagRx side by side.

Hers

Pros

  • +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
  • +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
  • +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance

1 more documented strengths

  • +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

  • −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
  • −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
  • −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care

2 more documented cautions

  • −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
  • −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

When would we choose Hers over Embody?

Hers is a useful alternative when you want to discuss an approved pill or injection through a women-focused platform. Its membership includes care-team access, weight tracking and dose-management support. Add the required membership to the prescribed medication price: the membership is $39 in month one and $149 per month afterward. Our Hers pricing record separates those charges.

Sources: Hers program and care details

What should you check before choosing Embody?

Embody's public catalogue lets you compare one month with longer prepaid terms. The semaglutide options are $79 for one month or $828 paid for twelve months, equivalent to $69 a month. The lower equivalent is a commitment, not a $69 monthly bill. Its separate promotional offer may carry different terms; confirm the charge and renewal shown during signup.

For an eligible patient who wants a compounded injection, that one-month option is our practical starting point. Clinical approval is required. Compounded medicines are not FDA approved, and paid plans are normally non-refundable; Embody publishes a limited exception for provider-determined medical disqualification. Compare the plan's fit before committing to a longer term.

Sources: Embody catalogue and payment terms · Embody cancellation and refund terms · FDA on compounded medicines

Keep narrowing the decision

What should you compare next?

Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.

Try Embody

Headline price: from $69/mo

Visit Embody

Reviews and pricing sources

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is Embody legit and is Hers legit, with the verification evidence behind each answer.